ORIGINAL RESEARCH
Published on 10 Jan 2025
Efficacy and safety of the combination of anlotinib and envafolimab in the treatment of unresectable or metastatic liposarcoma: findings from a single-center retrospective study
doi 10.3389/fonc.2024.1502945
- 249 views